Icon close

Close

Capabilities

Life Sciences and Healthcare

More than four hundred King & Spalding lawyers across our litigation, transactional and regulatory teams devote all or a substantial portion of their practice to serving clients in every segment of the Life Sciences and Healthcare sectors.

The comprehensive scope of the practice is unique: from helping to establish the start-ups developing the latest breakthrough drugs and medical devices, to defending the world’s largest pharmaceutical manufacturers in precedent-setting legal challenges, to representing major healthcare systems on their thorniest Medicare/Medicaid litigation or their strategic acquisitions, to counseling on the full spectrum of regulatory matters that these diverse entities face. We fully leverage our ability to draw on our broad experience as we work together to achieve outcomes that best protect and advance the interests of our clients across these sectors.

The lawyers in this group bring exceptionally deep industry and technical knowledge, many with advanced degrees in life sciences and medical fields as well as professional experience as scientists, surgeons, engineers, in-house lawyers and executives, senior regulators at the FDA, HHS and CMS, and enforcement officials at the DOJ.

Life Sciences

Named a four time winner of Law 360’s “Practice Group of the Year” (2016-2019), the firm currently represents more than 250 pharmaceutical, biotechnology and medical device manufacturers, including eight of the top 10 pharmaceutical/biotechnology manufacturers and eight of the top 10 medical device manufacturers. We offer clients our unique perspective at every stage of the product life cycle — from emerging growth company counseling on intellectual property, capital-raising transactions, license and corporate partnering agreements, and clinical trials, through FDA approval, manufacturing, marketing, commercial and post-approval regulatory, strategic M&A, and other corporate transactions, to litigation and government and internal investigation matters. Our government affairs lawyers also help our clients in the industry understand and navigate legislative and regulatory developments in Washington, D.C., and in state capitals across the country.

Healthcare

The firm has one of the largest practices in the U.S., representing organizations involved in the delivery of healthcare services and products across all facets of the legal issues they face.  We serve the entire spectrum of healthcare institutional providers, practitioners, payors, educators, researchers, inventors, suppliers, investors and manufacturers across the nation.

  • Our deep bench of litigators marshal a keen understanding of federal and commercial payor reimbursement mechanisms to craft novel and effective case strategies in False Claims Act lawsuits, commercial managed care disputes, government reimbursement suits and civil litigation.
  • Many of our regulatory lawyers have served in government themselves, experience they leverage across the gamut of compliance reviews and risk assessments, government investigations and enforcement actions, Medicare and Medicaid payment issues, government audits, labor, employment, health and environmental litigation, and in advocacy before the House, Senate, Department of Health & Human Services, Centers for Medicare & Medicaid, Food & Drug Administration and other executive branch agencies.
  • Our transactional lawyers have been intensely involved in the sweeping evolution of traditional healthcare entity ownership structures and the emergence of new alignments and financing techniques. From boardroom advice to steady guidance through mergers, acquisitions, innovative financings, private equity and other strategic investments, and restructurings, we offer clients a broad team of transactional lawyers who devote all or most of their time to serving our clients in the healthcare sector.
Read more

Digital Health

King & Spalding’s Digital Health Group has extensive experience guiding companies through a myriad of considerations as the delivery of healthcare becomes increasingly digital.

Read More

Private Equity

As private equity firms increasingly invest in the Life Sciences and Healthcare industry, our cohesive regulatory and transactional strengths ensure success through each phase of investment.

Read More

Focus on Women's Health

From start-ups to global corporations, our industry attorneys provide 360-degree support to companies that develop, manufacture and distribute products tailored specifically toward improving women’s health.

Read More

General Counsel’s Decision Tree for the Life Sciences Industry

K&S launches General Counsel Internal Investigations Decision Tree for the Life Sciences industry.

Explore Here
Icon video

Healthcare Thought Leadership – Hospital Price Transparency

King & Spalding partner Mark Polston discusses hospital price transparency.

Watch Now
Icon video

Key Developments in Healthcare Fraud and Abuse Enforcement

King & Spalding partners Sally Yates and Mike Paulhus discuss key developments in healthcare fraud and abuse enforcement.

Watch Now
Icon video

Trends Among Healthcare Providers and Payors

King & Spalding partner John Barnes discusses best practices when negotiating agreements between healthcare providers and commercial payors.

Watch Now
Icon video

The Key to a Successful Reimbursement Dispute

King & Spalding partner Amanda Hayes-Kibreab explains ways that healthcare providers can successfully challenge commercial payors’ reimbursement policies.

Watch Now

Ad Hoc Sunshine and State Law Compliance Group

King & Spalding’s Sunshine and State Law Compliance Group serves as a powerful industry advocate with respect to transparency laws for more than 100 members companies.

Read More

Surprise Billing and Price Transparency Group

In response to policy changes with healthcare transparency laws, King & Spalding established the Surprise Billing and Price Transparency Group to assist our clients in developing solutions to these new requirements.

Read More

International Marketing and Disclosure Compliance Group

The K&S International Ad Hoc Group is a coalition of 20+ pharma and medical device companies that focuses on international transparency/disclosure laws targeting manufacturers.

Read More

Related Lawyers

Mark D. Polston Washington, D.C.
Laura I. Bushnell Silicon Valley
Vanessa Yen New York
Mark S. Brown Washington, D.C.
Mark A. Jensen Washington, D.C.
Adam C. Solander Washington, D.C.
Christine E. Savage Washington, D.C.
Nikki Reeves Washington, D.C.

Recognized nationwide as ‘Healthcare: The Elite’


Chambers USA 2022

LMG Life Sciences named 20 K&S lawyers as ‘Life Sciences Stars’ in the 2021 edition


LMG Life Sciences

Ranked as one of the leading firms in Pharmaceutical and Medical Products Regulatory


Chambers USA

Named Medical Device "Firm of the Year"


LMG Life Sciences

Selected as a leading firm in the nation in the Life Sciences industry


Legal 500

Icon close

Close

Recognition

Recognized nationwide as ‘Healthcare: The Elite’


Chambers USA 2022

LMG Life Sciences named 20 K&S lawyers as ‘Life Sciences Stars’ in the 2021 edition


LMG Life Sciences

Ranked as one of the leading firms in Pharmaceutical and Medical Products Regulatory


Chambers USA

Named Medical Device "Firm of the Year"


LMG Life Sciences

Selected as a leading firm in the nation in the Life Sciences industry


Legal 500